Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness


Autoria(s): Lose, Felicity; Batra, Jyotsna; O'Mara, Tracy; Fahey, Paul; Marquart, Louise; Eeles, Rosalind; Easton, Douglas; Olama, Ali Amin Al; Kote-Jarai, Zsofia; Guy, Michelle; Muir, Ken; Lophatananon, Artitaya; Rahman, Aneela; Neal, David; Hamdy, Freddie; Donovan, Jenny; Chambers, Suzanne; Gardiner, Robert; Aitken, Joanne; Yaxley, John; Alexander, Kimberly; Clements, Judith; Spurdle, Amanda; Kedda, Mary-Anne
Data(s)

2011

Identificador

http://eprints.qut.edu.au/52225/

Publicador

Elsevier Inc.

Relação

DOI:10.1016/j.urolonc.2011.05.011

Lose, Felicity, Batra, Jyotsna, O'Mara, Tracy, Fahey, Paul, Marquart, Louise, Eeles, Rosalind, Easton, Douglas, Olama, Ali Amin Al, Kote-Jarai, Zsofia, Guy, Michelle, Muir, Ken, Lophatananon, Artitaya, Rahman, Aneela, Neal, David, Hamdy, Freddie, Donovan, Jenny, Chambers, Suzanne, Gardiner, Robert, Aitken, Joanne, Yaxley, John, Alexander, Kimberly, Clements, Judith, Spurdle, Amanda, & Kedda, Mary-Anne (2011) Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urologic Oncology: Seminars and Original Investigations, Online(Online), pp. 1-9.

Fonte

Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #111200 ONCOLOGY AND CARCINOGENESIS #Prostate cancer, Kallikreins, Single nucleotide polymorphism
Tipo

Journal Article